Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Breaking News

Teva bids $40bn for Mylan in generics megamerger

A merger with Mylan would “transform the global generics space” says Teva, which has entered a $40bn bid as an alternative to the recently proposed Mylan-Perrigo merger.

Anti-fungal shows promise for cancer breakthrough in preclinical tests

An anti-fungal drug shows potential to treat a range of cancers, according to research from the Repurposing Drugs in Oncology (ReDO) project.

Allergan axing a further 577 at Cali HQ, post-Actavis acquisition

Almost 600 staff at Allergan’s headquarters in Irvine, California, will be laid off in the Botox maker’s latest round of job cuts.

US-Cuban embargo nears end as Pfizer and Regeneron make trade trip

Pfizer and Regeneron are in Cuba this week, scouting the country for business opportunities.

‘We must not rest on our laurels’

GEA revenue growth for 2015 overshadowed by 1,450 job cuts

GEA said it expects to achieve a moderate organic growth in revenue and an operating EBITDA of between €580 and €620m in the current fiscal year 2015, but its growth is overshadowed by 1,450 job cuts.

J&J to increase wearable insulin patch-pump production

Johnson & Johnson will scale up manufacturing of a three-day wearable patch pump used to deliver insulin, in preparation for a post 2015 launch.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...